ResMed Inc. will make Propeller Health a standalone unit within its Respiratory Care business, augmenting its current lineup of products for chronic obstructive pulmonary disease (COPD), following a $225m acquisition of the privately held Madison, Wisc., company.
Propeller's "digital medicine platform" is a mobile app that communicates with small sensors attached to inhaler devices used by asthma and COPD patients to track their use of medication while...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?